(S)-4-Benzyl-3-propionyl-2-oxazolidinone
CAS : 101711-78-8
Ref. 3D-FB18347
1g | Arrêté | ||
2g | Arrêté | ||
5g | Arrêté | ||
10g | Arrêté | ||
25g | Arrêté |
Informations sur le produit
- (4S)-3-(1-Oxopropyl)-4-(phenylmethyl)-2-oxazolidinone(+)-4-Benzyl-3-propionyl-2-oxazolidinone(4S)-4-Benzyl-3-propanoyloxazolidin-2 -one
- (4S)-4-Benzyl-3-propanoyl-1,3-oxazolidin-2-on
- (4S)-4-Benzyl-3-propionyl-1,3-oxazolidin-2-one
- 2-Oxazolidinone, 3-(1-oxopropyl)-4-(phenylmethyl)-, (4S)-
- (4S)-4-benzyl-3-propanoyl-1,3-oxazolidin-2-one
- (S)-4-benzyl-3-propionyl-2-oxazolidinone
- (S)-4-Benzyl-3-Propionyl-Oxazolidin-2-One
(S)-4-Benzyl-3-propionyl-2-oxazolidinone is a monomer that belongs to the group of spirocyclization. It has been shown to be neurotrophic and to have antiinflammatory effects in mice, which may be due to its ability to stabilize the cell membrane by forming an ion channel. (S)-4-Benzyl-3-propionyl-2-oxazolidinone is also a chiral molecule that can be deuterated, with one or more hydrogen atoms replaced with deuterium. This substitution can cause changes in the rate at which the drug binds with other molecules, leading to a change in pharmacological activity. The mechanism by which this occurs is not well understood, but mathematical model studies have shown that it can be mediated through the hydrogen bond network that stabilizes the molecule.